Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 14,902 | 18,865 | 15,267 | 14,486 | 9,455 |
| Operating Income | -14,902 | -18,865 | -15,267 | -14,486 | -9,455 |
| Interest Expense | 16 | 14 | 7 | 9 | 3 |
| Other Income | 60 | 28 | 0 | 0 | 0 |
| Pre-tax Income | -14,858 | -18,851 | -15,274 | -14,495 | -9,458 |
| Net Income Continuous | -14,858 | -18,851 | -15,274 | -14,495 | -9,458 |
| Net Income | $-14,858 | $-18,851 | $-15,274 | $-14,495 | $-9,458 |
| EPS Basic Total Ops | -466.63 | -150,169.40 | -336,734.70 | -495,198.10 | -51,325.66 |
| EPS Basic Continuous Ops | -466.92 | -113,152.60 | -336,569.30 | -495,478.30 | -51,247.70 |
| EPS Diluted Total Ops | -466.63 | -150,169.40 | -336,734.70 | -495,198.10 | -51,325.66 |
| EPS Diluted Continuous Ops | -466.92 | -113,152.60 | -336,569.30 | -495,478.30 | -51,247.70 |
| EPS Diluted Before Non-Recurring Items | -466.63 | -150,060.00 | -336,734.69 | -47,723.86 | -51,325.66 |
| EBITDA(a) | $-14,899 | $-18,861 | $-15,255 | $-14,473 | $-9,444 |